Facebook
X
LinkedIn
ForwardConference Guide
Miami Cancer Institute Skin Cancer Conference, Second Annual
Wednesday, August 27, 2025 | 5:00 - 8:30 p.m.
Claim CME/CE Credit
Option 1: Text the six-letter code provided at the end of the conference to (754) 203-8885. You will receive a message confirming your attendance.
Option 2: Scan the QR code shown below with your mobile phone, and enter the six-letter code provided at the conference to receive your credit.
Evaluation
Once you have claimed your CME/CE credit, you will receive a link to your evaluation form via email and SMS.
Presentations
| 5:00 p.m. - 5:30 p.m. | Dinner and Visit Exhibits |
| 5:30 p.m. - 5:35 p.m. | Welcome & Introduction Naiara Braghiroli, M.D. |
| 5:35 p.m. - 5:50 p.m. | When to Refer a Patient to Dermatology Renata Ruiz, M.D. |
| 5:50 p.m. - 6:05 p.m. | Suspect Cutaneous T-Cell Lymphoma (CTCL) and When to Refer to an Oncologist Yuliya Linhares, M.D. |
| 6:05 p.m. - 6:20 p.m. | Facial Melanoma - What Should You Suspect? Naiara Braghiroli, M.D |
| 6:20 p.m. - 6:35 p.m. | Signs and Symptoms of Head and Neck Cancer Geoffrey Young, M.D. |
| 6:35 p.m. - 6:50 p.m. | Questions and Answers Naiara Braghiroli, M.D. |
| 6:50 p.m. - 7:05 p.m. | Break and Visit Exhibits |
| 7:05 p.m. - 7:20 p.m. | Can the Type of Skin Biopsy Affect the Correct Staging of Melanoma? Ramon Jimenez, M.D. |
| 7:20 p.m. - 7:35 p.m. | Indications for MOHS Micrographic Surgery in Skin Cancer Micheal Raisch, M.D. |
| 7:35 p.m. - 7:50 p.m. | Superficial Radiation Therapy: Indications, Pros and Cons Noah Kalman, M.D. |
| 7:50 p.m. - 8:05 p.m. | Updates on Immunotherapy for Cutaneous Oncology Cesar E. Ochoa, M.D. |
| 8:05 p.m. - 8:20 p.m. | Questions and Answers Naiara Braghiroli, M.D. |
| 8:20 p.m. - 8:30 p.m. | Closing Remarks / Adjourn Naiara Braghiroli, M.D. |
NOTE: Schedule subject to change.
Disclosures and Resolution of Conflict of Interest
The following individuals do not have relevant financial relationships with ineligible companies*. (** Indicates that this individual’s presentation(s) will include discussion of off-label or unapproved usage.)
Naiara Braghiroli, M.D.
Ramon Jimenez, M.D.
Noah Kalman, M.D.
Yuliya Linhares, M.D.**
Cesar Ochoa, M.D.
Michael Raisch, M.D.
Renata Ruiz, M.D.
Geoffrey Young, M.D.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.